| 000 | 01104nam a2200301 a 4500 | ||
|---|---|---|---|
| 008 | 160413s2016^^^^ne^af^^^^^^^^^000^0^eng^d | ||
| 020 | _a9780128010761 | ||
| 020 | _a0128010762 | ||
| 035 | _aMX001001894364 | ||
| 040 |
_aDNLM _bspa _erda _cDNLM _dUNAMX |
||
| 050 | 4 |
_aRS420 _bK46 2016 |
|
| 082 | 0 | 4 |
_a615/.19 _222 |
| 100 | 1 |
_aDi, Li, _eautor |
|
| 245 | 1 | 0 |
_aDrug-like properties : _bconcepts, structure design and methods : from ADME to toxicity optimization / _cby Li Di and Edward H. Kerns |
| 250 | _aSecond edition | ||
| 264 | 1 |
_aAmsterdam : _bElsevier Academic Press, _c[2016] |
|
| 264 | 4 | _c©2016 | |
| 300 |
_axvii, 560 páginas : _bilustraciones (algunas a color) |
||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 500 | _aEn la edición previa las menciones de responsabilidad aparecen invertidas | ||
| 650 | 4 | _aQuímica farmacéutica | |
| 650 | 4 |
_aMedicamentos _xRelaciones estructura-actividad |
|
| 650 | 4 | _aDesarrollo de medicamentos | |
| 650 | 4 |
_aMedicamentos _xDiseño |
|
| 700 | 1 |
_aKerns, Edward Harvel, _eautor |
|
| 999 |
_c3248 _d3248 |
||